Baird advocates medtech companies such as Alcon, Stryker, and Cooper due to product and pricing strengths. Belief is strong in Alcon's 2024 margin possibilities, Stryker's premium pricing and predicted robust orthopedic demand, and projected revenue growth for Boston Scientific and Axonics.
Gapping up $リヴィアン・オートモーティブ(RIVN.US)$+6% (The company reported a first-quarter loss that was narrower than expected. Rivian also said it's still on track to meet a 50,000-vehicle production target for 2023.) $セルシウス・ホールディングス(CELH.US)$+11.1% (The company posted a strong earnings report. Celsius posted 40 cents in earnings per share for the first quarter, more than doubling the 19-cent consensus estimate of analysts polled by Str...
Exact Sciences Price Target Raised to $85.00/Share From $55.00 by Craig-Hallum $イグザクド・サイエンシズ(EXAS.US)$Price Target Raised to $85.00/Share From $55.00 by Craig-Hallum. Baird Upgrades Alcon to Outperform, Raises Price Target to $90 Baird analyst Jeff Johnson upgrades$アルコン(ALC.US)$from Neutral to Outperform and raises the price target from $75 to $90. BofA Securities Upgrades Celsius Holdings to Buy, Raises Price Target to $125 B o...
Jefferies Downgraded to Market Perform From Outperform at Keefe Bruyette Keefe Bruyette analyst Michael Brown downgraded$ジェフリーズ・ファイナンシャル・グループ(JEF.US)$to Market Perform from Outperform with a price target of $37, down from $38. Jefferies faced a tough operating environment in Q4 due to weaker than expected equity capital markets and advisory revenues as well as a higher comp ratio, Brown tells investors in a research note. Coupa Softwa...
アルコンに関するコメント
コラムToday's Pre-Market Stock Movers: ABNB, RIVN, AFRM, SPCE and More
$リヴィアン・オートモーティブ(RIVN.US)$ +6% (The company reported a first-quarter loss that was narrower than expected. Rivian also said it's still on track to meet a 50,000-vehicle production target for 2023.)
$セルシウス・ホールディングス(CELH.US)$ +11.1% (The company posted a strong earnings report. Celsius posted 40 cents in earnings per share for the first quarter, more than doubling the 19-cent consensus estimate of analysts polled by Str...
コラムUS Top Rating Updates on 5/10: PYPL, EXAS, CELH, GTLB and More
$イグザクド・サイエンシズ(EXAS.US)$ Price Target Raised to $85.00/Share From $55.00 by Craig-Hallum.
Baird Upgrades Alcon to Outperform, Raises Price Target to $90
Baird analyst Jeff Johnson upgrades $アルコン(ALC.US)$ from Neutral to Outperform and raises the price target from $75 to $90.
BofA Securities Upgrades Celsius Holdings to Buy, Raises Price Target to $125
B o...
コラムUS Top Gap Ups and Downs on 5/3: AMD, VOD, SBUX, EL and More
Gap Ups
1. $ユーナム・グループ(UNM.US)$ - up 5.1%
2. $ジェネラック・ホールディングス(GNRC.US)$ - up 5.0%
3. $ビルダーズ・ファースト・ソース(BLDR.US)$ - up 4.9%
4. $Livent(LTHM.US)$ - up 4.4%
5. $ピアソン(PSO.US)$ - up 4.1%
6. $ベリスク・アナリティックス(VRSK.US)$ - up 3.6%
7. $アシュラント(AIZ.US)$ - up 2.7%
8. $ボーダフォン・グループ(VOD.US)$ - up...
AKO Capital:
コラムUS Top Gap Ups and Downs on 4/21: SAP, PG, NVO, WRB and More
Gap Ups
1. $エスエイピー(SAP.US)$ - up 3.2%
2. $フレゼニウス・メディカル・ケア(FMS.US)$ - up 3.1%
3. $HCAヘルスケア(HCA.US)$ - up 2.2%
4. $プロクター・アンド・ギャンブル(PG.US)$ - up 2.1%
5. $ノボ・ノルディスク(NVO.US)$ - up 1.5%
6. $アルコン(ALC.US)$ - up 1.2%
7. $サイバーアーク・ソフトウェア(CYBR.US)$ - up 1.0%
8. $アカディア・ヘルスケア(ACHC.US)$ - up 0.9%...
コラムUS Top Gap Ups and Downs on 4/10: MU, WDC, BIDU, UMC and More
Gap Ups
1. $パイオニア ナチュラル リソーシーズ(PXD.US)$ - up 4.1%
2. $マイクロン テクノロジー(MU.US)$ - up 3.1%
3. $ウエスタンデジタル(WDC.US)$ - up 3.0%
4. $サイトワン・ランドスケープ・サプライ(SITE.US)$ - up 1.1%
5. $EQTコーポレーション(EQT.US)$ - up 0.7%
6. $ネットアップ(NTAP.US)$ - up 0.6%
7. $チョンホア・テレコム (中華電信)(CHT.US)$ - up 0.3%...
コラムUS Top Gap Ups and Downs on 3/30: PHG, JD, OSH, LOGI and More
Gap Ups
1. $ロイヤルフィリップス(PHG.US)$ - up 4.5%
2. $Oak Street Health(OSH.US)$ - up 4.3%
3. $JD.COM(京東商城)(JD.US)$ - up 3.7%
4. $アングロゴールド・アシャンティ(AU.US)$ - up 3.2%
5. $アルコン(ALC.US)$ - up 3.0%
6. $BHPグループ(BHP.US)$ - up 2.6%
7. $LMエリクソン(ERIC.US)$ - up 2.5%
8. $ペイコム・ソフトウエア(PAYC.US)$ - up 2.1%...
コラムUS Top Rating Updates on 12/22: JEF, COUP, BSX, COO and More
Keefe Bruyette analyst Michael Brown downgraded $ジェフリーズ・ファイナンシャル・グループ(JEF.US)$ to Market Perform from Outperform with a price target of $37, down from $38. Jefferies faced a tough operating environment in Q4 due to weaker than expected equity capital markets and advisory revenues as well as a higher comp ratio, Brown tells investors in a research note.
Coupa Softwa...
コラムUS Top Gap Ups and Downs on 12/16: ADBE, ACN, SE, VOD and More
Gap Ups
1. $イグザクド・サイエンシズ(EXAS.US)$ - up1.35%
2. $コリア・エレクトリック・パワー(KEP.US)$ - up 2.65%
3. $アドビ(ADBE.US)$ - up 0.81%
Gap Downs
1. $フランコ-ネバダ(FNV.US)$- down 1.35%
2. $ノキア(NOK.US)$ - down 2.29%
3. $サンラン(RUN.US)$ - down 1.78%
4. $プロロジス(PLD.US)$ - down 1.77%
5. $ロジテック・インターナショナル(LOGI.US)$ - down 1....
まだコメントはありません